Methylation status of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene promoter in World Health Organization grade III gliomas

Journal of Korean Neurosurgical Society

Volumn 46, Issue 4, 2009, Pages 385-388

  Yang, Seung Heon ^a   Kim, Yong Hwy ^a   Kim, Jin Wook ^a   Park, Chul Kee ^a   Park, Sung Hye ^a   Jung, Hee Won ^a  

^a Seoul National University   (South Korea)

Author keywords

1p 19q; Methylation; Methylation specific PCR; MGMT gene promoter; Oligodendroglioma

Indexed keywords

EPIDERMAL GROWTH FACTOR; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE SILENCING; GENETIC EPIGENESIS; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHYLATION; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; PROTEIN EXPRESSION; WORLD HEALTH ORGANIZATION;

EID: 72949120814     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2009.46.4.385     Document Type: Article

References (18)

1. Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM, et al. : Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 144 : 134-142, 2003
2. Balana C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, et al. : O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 9 : 1461-1468, 2003
3. Dong SM, Pang JC, Poon WS, Hu J, To KF, Chang AR, et al. : Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol 60 : 808-816, 2001
4. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. : Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343 : 1350-1354, 2000
5. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG : Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59 : 793-797, 1999
6. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 : 997-1003, 2005
7. Jeon YK, Park K, Park CK, Paek SH, Jung HW, Park SH : Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors : a clinicopathological study using fluorescence in situ hybridization. Neuropathology 27 : 10-20, 2007
8. Kleihues P, Burger PC, Scheithauer BW : The new WHO classification of brain tumours. Brain Pathol 3 : 255-268, 1993
9. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. : The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 : 215-225; discussion 226-229, 2002
10. Kuo LT, Kuo KT, Lee MJ, Wei CC, Scaravilli F, Tsai JC, et al. : Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors. Int J Cancer 124 : 2872-2879, 2009
11. Lavon I, Zrihan D, Zelikovitch B, Fellig Y, Fuchs D, Soffer D, et al. : Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. Clin Cancer Res 13 : 1429-1437, 2007
12. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. : The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 : 97-109, 2007
13. Möllemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G : Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 113 : 379-385, 2005
14. Nutt CL, Noble M, Chambers AF, Cairncross JG : Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res 60 : 4812-4818, 2000
15. Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, et al. : CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res 10 : 4933-4938, 2004
16. Pegg AE : Mammalian O6-alkylguanine-DNA alkyltransferase : regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50 : 6119-6129, 1990
17. Scheithauer BW, Fuller GN, VandenBerg SR : The 2007 WHO classification of tumors of the nervous system : controversies in surgical neuropathology. Brain Pathol 18 : 307-316, 2008
18. van den Bent MJ, Kros JM : Predictive and prognostic markers in neuro-oncology. J Neuropathol Exp Neurol 66 : 1074-1081, 2007